Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study

被引:0
|
作者
Jaehyun Lim
You-Jung Choi
Bong Sung Kim
Tae-Min Rhee
Hyun-Jung Lee
Kyung-Do Han
Jun-Bean Park
Jin Oh Na
Yong-Jin Kim
Heesun Lee
Hyung-Kwan Kim
机构
[1] Seoul National University Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Korea University College of Medicine,Division of Cardiology, Department of Internal Medicine
[4] Soongsil University,Department of Statistics and Actuarial Science
[5] Seoul National University Hospital Healthcare System Gangnam Center,Division of Cardiology, Department of Internal Medicine
[6] Seoul National University College of Medicine,Diagnostic Test Unit Section of Cardiovascular Imaging, Division of Cardiology, Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital,
来源
关键词
Sodium-glucose co-transporter-2 inhibitors ; Dapagliflozin; Empagliflozin; Cardiovascular risk; Heart failure; Cardiovascular death;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study
    Lim, Jaehyun
    Choi, You-Jung
    Kim, Bong Sung
    Rhee, Tae-Min
    Lee, Hyun-Jung
    Han, Kyung-Do
    Park, Jun-Bean
    Na, Jin Oh
    Kim, Yong-Jin
    Lee, Heesun
    Kim, Hyung-Kwan
    [J]. CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] Dapagliflozin versus Empagliflozin and the Risk for Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Nationwide Population-Based Study
    Lim, Jaehyun
    Kim, Bongseong
    Choi, You-Jung
    Lee, Hyun-Jung
    Han, Kyung-Do
    Lee, Heesun
    Park, Jun-bean
    Kim, Hyung-Kwan
    Kim, Yong-Jin
    [J]. CIRCULATION, 2022, 146
  • [3] COMPARATIVE RISK OF HEART FAILURE HOSPITALIZATIONS ASSOCIATED WITH DAPAGLIFLOZIN VS. EMPAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS: A POPULATION-BASED COHORT STUDY
    Shao, S. C.
    Chang, K. C.
    Chen, Y. H.
    Chan, Y. Y.
    Chen, H. Y.
    Lai, E. C. C.
    [J]. VALUE IN HEALTH, 2019, 22 : S544 - S545
  • [4] Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
    Kim, Jee-Heon
    Yoon, Young-Chae
    Kim, Young-Hoon
    Park, Jong-Il
    Choi, Kang-Un
    Nam, Jong-Ho
    Lee, Chan-Hee
    Son, Jang-Won
    Park, Jong-Seon
    Kim, Ung
    [J]. CLINICAL CARDIOLOGY, 2024, 47 (03)
  • [5] Risk of cardiovascular and mortality outcomes in Korean type 2 diabetes and prediabetes: a nationwide population-based cohort study
    Yun, J. -S.
    Lee, E. -Y.
    Song, K. -H.
    Ahn, Y. -B.
    Kim, K.
    Ko, S. H.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S132 - S133
  • [6] Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real-World Observation Using a Nationwide, Population-Based Cohort
    Lim, Jaehyun
    Kwak, Soongu
    Choi, You-Jung
    Rhee, Tae-Min
    Park, Chan Soon
    Kim, Bongseong
    Han, Kyung-Do
    Lee, Heesun
    Park, Jun-Bean
    Kim, Yong-Jin
    Lee, Hyun-Jung
    Kim, Hyung-Kwan
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (03):
  • [7] Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes
    Singh, Sahib
    Garg, Aakash
    Tantry, Udaya S.
    Bliden, Kevin
    Gurbel, Paul A.
    Gulati, Martha
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2024, 218 : 24 - 31
  • [8] Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: a population-based cohort study
    Douros, Antonios
    Dell'Aniello, Sophie
    Yu, Oriana
    Suissa, Samy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 417 - 418
  • [9] Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study
    Douros, Antonios
    Dell'Aniello, Sophie
    Yu, Oriana Hoi Yun
    Suissa, Samy
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (02): : 254 - 262
  • [10] Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Yu, Teng-Shun
    Hsu, Chung Y.
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (22)